Luke Lightning
12 SlideShares 213 Followers 560 Folgens
Personal Information
Unternehmen/Arbeitsplatz
San Francisco, California United States
Beruf
Entrepreneur, Biotech, Drug Discovery and Development, University Teaching Experience
Branche
Medical / Health Care / Pharmaceuticals
Webseite
http://alquest.us/
Info
• 15+ years in biotech and pharma profession: Research and Development team leader • Preclinical PK and bioanalytical study administrator: designed preclinical DMPK and bioanalytical protocols implemented by CROs that allowed for “go/no go” decisions within budget • Early discovery, preclinical and clinical team experience: worked on early discovery and preclinical project teams as well as on programs involving Phase 1 and Phase 2 clinical candidates • Managed DMPK programs running concurrently in several therapeutic areas: cardiovascular, gastrointestinal, antiviral, and neurological disorders • Entrepreneurial spirit: identified new potential therapeutic opportunities for...
Kontaktdetails
Tags
cyp2c9 cyp3a4 cyp450s adducts mechanism-based inactivation mass spectrometry
Mehr anzeigen

Präsentationen

(11)
Alle anzeigen

Kinetics of glyburide metabolism by humans and baboons using liver and placental tissues

Vor 12 Jahren • 1242 Aufrufe

Molecular analysis of whole body animal tissue secitions by imaging maldi ms

Vor 12 Jahren • 694 Aufrufe

Osteoporosis Therapy Overview

Vor 12 Jahren • 3912 Aufrufe

Introduction to pharmacology and drug metabolism

Vor 12 Jahren • 11589 Aufrufe

Microscale culture of human liver cells for drug development

Vor 12 Jahren • 1487 Aufrufe

Butyrylcholinesterase Overview: Substrates Inhibitors Structure Mechanism Therapeutic Indications

Vor 11 Jahren • 10499 Aufrufe

CYP2C9 Haplotype Structure and Association with Clinical Outcomes

Vor 11 Jahren • 2170 Aufrufe

Lightning Deloitte Patheon QB3 Talk 2012

Vor 11 Jahren • 839 Aufrufe

Mass spectrometric analysis of cyp450s following mechanism based inactivation Lightning 2012

Vor 11 Jahren • 591 Aufrufe

Hydrolysis of pyrethroids by human and rat tissues

Vor 11 Jahren • 998 Aufrufe

Human esterases: Chemical and Biochemical Considerations

Vor 11 Jahren • 12180 Aufrufe

Dokumente

(1)

Involvement of multiple P450s and UDP-GTs in the in vitro metabolism of Muraglitazar

Vor 12 Jahren • 586 Aufrufe
Personal Information
Unternehmen/Arbeitsplatz
San Francisco, California United States
Beruf
Entrepreneur, Biotech, Drug Discovery and Development, University Teaching Experience
Branche
Medical / Health Care / Pharmaceuticals
Webseite
http://alquest.us/
Info
• 15+ years in biotech and pharma profession: Research and Development team leader • Preclinical PK and bioanalytical study administrator: designed preclinical DMPK and bioanalytical protocols implemented by CROs that allowed for “go/no go” decisions within budget • Early discovery, preclinical and clinical team experience: worked on early discovery and preclinical project teams as well as on programs involving Phase 1 and Phase 2 clinical candidates • Managed DMPK programs running concurrently in several therapeutic areas: cardiovascular, gastrointestinal, antiviral, and neurological disorders • Entrepreneurial spirit: identified new potential therapeutic opportunities for...
Tags
cyp2c9 cyp3a4 cyp450s adducts mechanism-based inactivation mass spectrometry
Mehr anzeigen